Filing Details
- Accession Number:
- 0001213900-23-045386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-02 08:00:18
- Reporting Period:
- 2023-06-01
- Accepted Time:
- 2023-06-02 08:00:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690080 | 180 Life Sciences Corp. | ATNF | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1132679 | Lawrence Steinman | 3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto CA 94306 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-01 | 18,000 | $1.23 | 48,129 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.